title: A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT.
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: T
authors.initials: T
authors.lastname: Tachibana
authors.forename: A
authors.initials: A
authors.lastname: Numata
authors.forename: H
authors.initials: H
authors.lastname: Takasaki
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
authors.forename: A
authors.initials: A
authors.lastname: Maruta
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigatsubo
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D005293:Ferritins / Q000097:blood*; D006086:Graft vs Host Disease / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007938:Leukemia / Q000097:blood / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D019172:Transplantation Conditioning
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D005293:Ferritins